Why are epilepsy trials failing? Interview with Russell Katz. (November 2011)

• Record Type: Journal Article
• Authors: Katz, Russell
• Is Part Of: Clinical investigation. Volume 1:Number 11(2011)
• Page Start: 1487
• Page End: 1489
• Publication Date: 2011-11
• Subjects: Drugs -- Testing -- Periodicals; Drug development -- Periodicals; Clinical trials -- Periodicals; 615.580724
• DOI: 10.4155/cli.11.131
• Languages: English
• ISSNs: 2041-6806

Abstract

Russell Katz is the director of the Division of Neurology Products in the US FDA''s Center for Drug Evaluation and Research. Katz''s division is responsible for regulating research with investigational treatments for neurologic diseases, including epilepsy, as well as making decisions about which treatments should be approved. He has written and lectured extensively about all aspects of the development of treatments for neurologic diseases. Katz speaks to Laura Harvey at the journal, on the difficulties facing antiepilepsy drug trials today.